Protease Inhibitor Task Force: Opportunity for Participation

The February 23-24 meeting of the National Task Force on AIDS
Drug Development (NTFADD), especially February 23, may be a
pivotal moment in the development of protease inhibitors.
Activists want the NTFADD to appoint an official protease
inhibitor task force which can work effectively to find ways
to make the drugs accessible to patients; to facilitate
research in combination therapies, cross resistance, etc.; to
facilitate collaboration and sharing in research; and to
overcome corporate and regulatory barriers. Note that those
who want to speak at the meeting should make advance
arrangements by February 9 (see AIDS TREATMENT NEWS #214,
January 6, 1995, page 8).

For background on the proposed protease inhibitor task force,
see AIDS TREATMENT NEWS #210, November 4, 1994. If you can
help, call Jules Levin at 718/624-8541.